Histidine Ammonia-Lyase (HAL) Peptide
HAL
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN937635
Quick Overview for Histidine Ammonia-Lyase (HAL) Peptide (ABIN937635)
Target
HAL
(Histidine Ammonia-Lyase (HAL))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Peptide Type
- Synthetic
-
Sequence
- EAAHRLLLEQ KVWEVAAPYI EKYRMEHIPE SRPLSPTAFS LQFLHKKSTK
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of HAL antibody,
Alternative Names: HAL control peptide, HAL antibody Blocking Peptide, Anti-HAL Blocking Peptide, Histidine Ammonia-Lyase Blocking Peptide, HIS Blocking Peptide, HSTD Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- HAL (Histidine Ammonia-Lyase (HAL))
-
Background
- HAL is a cytosolic enzyme catalyzing the first reaction in histidine catabolism, the nonoxidative deamination of L-histidine to trans-urocanic acid. HAL defects cause histidinemia which is characterized by increased histidine and histamine and decreased urocanic acid in body fluidsHistidine ammonia-lyase is a cytosolic enzyme catalyzing the first reaction in histidine catabolism, the nonoxidative deamination of L-histidine to trans-urocanic acid. Histidine ammonia-lyase defects cause histidinemia which is characterized by increased histidine and histamine and decreased urocanic acid in body fluids.
-
Molecular Weight
- 72 kDa
Target
-
You are here:
